The latest price target for Healthcare Realty Trust (NYSE:HR) was reported by JP Morgan on December 20, 2024. The analyst firm set a price target for $19.00 expecting HR to rise to within 12 months (a possible 12.56% upside). 15 analyst firms have reported ratings in the last year.

The latest analyst rating for Healthcare Realty Trust (NYSE:HR) was provided by JP Morgan, and Healthcare Realty Trust downgraded their neutral rating.

The last upgrade for Healthcare Realty Trust Inc happened on October 24, 2023 when BTIG raised their price target to $17. BTIG previously had a neutral for Healthcare Realty Trust Inc.

The last downgrade for Healthcare Realty Trust Inc happened on December 20, 2024 when JP Morgan changed their price target from N/A to $19 for Healthcare Realty Trust Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Realty Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Realty Trust was filed on December 20, 2024 so you should expect the next rating to be made available sometime around December 20, 2025.

While ratings are subjective and will change, the latest Healthcare Realty Trust (HR) rating was a downgraded with a price target of $0.00 to $19.00. The current price Healthcare Realty Trust (HR) is trading at is $16.88, which is within the analyst’s predicted range.